基于抗的新型抗微生物药物向了格拉姆阳性和格拉姆阴性细菌病原体的膜
Tarosha Salpadoru1, Kevin E Pinks2, Jacob A Lieberman1
1Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
Microbiology spectrum
|April 23, 2024
概括
新的抗化合物显示出对抗抗生素耐药细菌的承诺. SbPh4ACO表现出广泛的杀菌活性,并增强了现有的抗生素的有效性,具有低细胞毒性.
科学领域:
- 药用化学 医学化学
- 抗菌剂 抗菌剂 抗菌剂
- 纳米技术 纳米技术
背景情况:
- 抗菌素耐药性 (AMR) 是一个全球性的健康危机,需要新的治疗策略.
- 基于金属的化合物,特别是衍生物,正在重新成为潜在的抗菌剂.
- 新型有机反 ((V) 化合物复合与蓝酸盐已经显示出先前的抗微生物潜力.
研究的目的:
- 评估五种新型有机抗化合物对关键细菌病原体的抗菌功效.
- 为了研究最有效的化合物SbPh4ACO的作用机制和协同潜力.
- 评估SbPh4ACO作为对抗耐药菌株现有抗生素的增强剂的治疗潜力.
主要方法:
- 针对Pseudomonas aeruginosa,大肠杆菌和金黄色葡萄球菌的抗菌疗效测试.
- 确定最小抑制度 (MIC) 和最小杀菌度 (MBC).
- 超薄电子显微镜和膜透性测试以阐明作用机制.
- 与聚米辛B和塞福西丁的协同效应测试,以及哺乳动物细胞系的细胞毒性评估.
主要成果:
- SbPh4ACO对所有三种测试的细菌菌株 (MIC:50-100μg/mL) 显示出广泛的杀菌活性.
- 在细菌中,SbPh4ACO处理诱导了膜破坏和增加了膜透性.
- 在非细胞毒性度下,SbPh4ACO与多素B和塞福西丁显示出协同作用.
结论:
- 新型抗氧基化合物SbPh4ACO具有针对格拉姆阳性和格拉姆阴性病原体的显著抗菌潜力.
- SbPh4ACO的机制涉及细菌膜的破坏,为打击AMR提供了一个新的途径.
- SbPh4ACO可以增强现有抗生素的作用,这表明它在抗药性感染的联合治疗中具有实用性.
相关概念视频
Antimicrobial Proteins
984
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
984
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K


